PDL BioPharma :
Develops humanized monoclonals to prevent and treat autoimmune disease, inflammatory conditions, cancers and viral infections. Includes clinical trials
in ...
http://www.pdl.com/...
|
BioSpace - PDL BioPharma, Inc. News, Search Jobs, Events
PDL BioPharma, Inc. is focused on developing innovative therapies to treat severe and life-threatening illnesses. From our research labs to our clinical
...
http://www.biospace.com/company_profile.aspx?CompanyId=10011...
|
PDL BioPharma : Content Unavailable
PDL BioPharma · Management Board of Directors Corporate Governance ... Please check our Site Map. Terms of Use Contact Us ©2006 PDL BioPharma, Inc.
http://www.pdl.com/index.cfm?navID=90...
|
PDL BioPharma Reports Third Quarter 2008 Financial Results and ...
PDL BioPharma Reports Third Quarter 2008 Financial Results and Updates 2008 Guidance for Royalty Revenues. - REDWOOD CITY, CA--(MARKET WIRE)--Nov 6, ...
http://biz.yahoo.com/iw/081106/0449997.html...
|
PDL BioPharma : Careers : Benefits
At PDL BioPharma, we provide our employees with outstanding benefits, provide vehicles for them to save and plan for retirement and reward outstanding ...
http://www.pdl.com/index.cfm?navId=75...
|
Live Call: PDL BioPharma Earnings Conference Call (Q3 2008 ...
Learn when companies announce their quarterly, annual earnings as well as other types of announcements. Listen to the conference call and remind yourself by ...
http://biz.yahoo.com/cc/4/98534.html...
|
PDL BioPharma : Investors : 2008 News Releases
PDL BioPharma Declares $500 Million Special Cash Dividend and Announces Plan to Separate Its Biotechnology Operations From Its Antibody Humanization Royalty ...
http://www.pdl.com/index.cfm?navId=22...
|
PDL BioPharma Announces November 6 Webcast of Third Quarter 2008 ...
24 Oct 2008 ... PDL BioPharma Announces November 6 Webcast of Third Quarter 2008 Financial Results Conference Call. - REDWOOD CITY, CA--(MARKET WIRE)--Oct ...
http://biz.yahoo.com/iw/081024/0446297.html...
|
PDL BioPharma, Inc. Appoints John P. McLaughlin to Become ...
Following the planned spin-off, McLaughlin will lead the remaining royalty company, which will continue to operate under the PDL BioPharma name. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=116299...
|
Bristol-Myers Squibb and PDL BioPharma Enter Global Alliance to ...
Bristol-Myers Squibb and PDL BioPharma Enter Global Alliance to Develop Novel Treatment for Multiple Myeloma. - PRINCETON, NJ & REDWOOD CITY, Calif.
http://biz.yahoo.com/bw/080819/20080819006170.html?.v=1...
|
